Sarcoma trials in Portugal

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  Where

  Coimbra, Lisbon, Loures, Porto, Vila Nova de Gaia

  Age

  18 years and over

  People

  400 worldwide

  Run by

  Hoffmann-La Roche

  See details and how to joinNCT07541170 · EU 2025-524263-21-01
• Phase 1Taking people
  A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

  Where

  Porto

  Age

  18 years and over

  People

  62 worldwide

  Run by

  Novartis Pharma AG

  See details and how to join2025-521702-18-00 · EU 2025-521702-18-00
• No phaseTaking people
  The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)

  Where

  Porto

  Age

  18 years and over

  People

  100 worldwide

  Run by

  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

  See details and how to joinNCT06408441
• Phase 1/2Taking people
  FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

  Where

  Coimbra, Lisbon, Porto

  People

  1,672 worldwide

  Run by

  University of Birmingham

  See details and how to joinNCT04625907 · EU 2024-510579-40-00